Plasma tetrahydrobiopterin and its pharmacokinetic following oral administration

被引:108
|
作者
Fiege, B
Ballhausen, D
Kierat, L
Leimbacher, W
Goriounov, D
Schircks, B
Thöny, B
Blau, N
机构
[1] Univ Zurich, Childrens Hosp, Div Clin Chem & Biochem, CH-8032 Zurich, Switzerland
[2] Univ Zurich, Childrens Hosp, Div Metab & Mol Pediat, CH-8032 Zurich, Switzerland
[3] Schircks Lab, CH-8645 Jona, Switzerland
关键词
PKU; hyperphenylalaninemia; biopterin; NOS; endothelial dysfunction;
D O I
10.1016/j.ymgme.2003.09.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tetrahydrobiopterin (BH4) is widely used as a therapeutic agent in patients with BH4 deficiencies and mild forms of phenylketonuria (PKU) and there is an increasing need for the measurement of its plasma concentrations in patients with cardiovascular disorders. We measured BH4 and total biopterin in dithioerythritol (DTE) pretreated plasma from four adults after oral administration of BH4 (2, 10, and 20 mg/kg body weight) using the differential iodine oxidation method. About 80% (range 64.8-92.2%) of total biopterin was found as BH4 when analyzed immediately after blood sampling. Compared with ascorbic acid as an antioxidant, DTE was more protective against oxidation of BH4, particularly in samples stored over a period of 8 months. Without antioxidant (DTE or ascorbic acid) almost no BH4 was detected. Furthermore, BH4 and total biopterin were measured at different time intervals (up to 33 h after oral administration) and pharmacokinetic parameters T-max (1-4 h), C-max (258.7-259.0 nmol/L biopterin at a dosage of 10 mg/kg), and area under the curve (AUC=1708-1958 nmol*h/L up to T=10 h) were estimated. The elimination half-life time was calculated to be 3.3-5.1 h. Doubling the BH4 dosage to 20 mg/kg resulted in 60% higher AUC while sublingual BH4 application (2 mg/kg) resulted in 58-76% higher BH4 plasma concentrations when compared with oral administration. These preliminary data suggest that in patients with BH4 cofactor defects and BH4-responsive phenylalanine hydroxylase deficiency, BH4 should be given in at least two to three daily doses and that sublingual administration may lower the required BH4 dosage and subsequently the cost of treatment. Due to inter individual differences in pharmacokinetic properties, in some patients with hyperphenylalaninemia and mild PKU plasma BH4 levels may be not high enough to fully activate the liver phenylalanine hydroxylase and thus lower blood phenylalanine levels. Assessment of plasma BH4 or total biopterin concentrations may be a good way to control the efficacy of the loading test. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:45 / 51
页数:7
相关论文
共 50 条
  • [1] PHARMACOLOGICAL STUDIES ON FURPROFEN - ITS PHARMACOKINETIC PROFILE AND ANTIINFLAMMATORY ACTION FOLLOWING ORAL-ADMINISTRATION
    PALUMBO, G
    FANINI, D
    PANTALEONI, GC
    CARLUCCI, G
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 1991, 4 (02) : 85 - 90
  • [2] Pharmacokinetic Interaction of Entinostat and Erlotinib in Rat Plasma Following Single and Co-Oral Administration in Rats
    Zheng, Yuancai
    Wang, Yilong
    Zhang, Likang
    Zhang, Qingwei
    Yang, Xuezhi
    Lin, Guanyang
    LATIN AMERICAN JOURNAL OF PHARMACY, 2014, 33 (07): : 1225 - 1228
  • [3] Pharmacokinetic study of mangiferin in human plasma after oral administration
    Hou, Shaoying
    Wang, Fang
    Li, Yingmei
    Li, Ying
    Wang, Maoqing
    Sun, Dianjun
    Sun, Changhao
    FOOD CHEMISTRY, 2012, 132 (01) : 289 - 294
  • [4] Pharmacokinetic parameters of meloxicam after its oral administration in goat
    Wani, A. R.
    Nabi, S. U.
    Bhat, S. A.
    Shah, O. S.
    Kutchy, N. A.
    Roy, R. K.
    VETERINARY WORLD, 2014, 7 (03) : 141 - 145
  • [5] Comparison of plasma pharmacokinetic profile of ivermectin following administration of subcutaneous injection (Baymec®) and oral tablet (Efektin®) in goats
    Gokbulut, C.
    Karademir, U.
    Boyacioglu, M.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2007, 30 (05) : 489 - 491
  • [6] PLASMA AND SKIN BLISTER FLUID CONCENTRATIONS OF TRIMETHOPRIM FOLLOWING ITS ORAL-ADMINISTRATION
    KLIMOWICZ, A
    NOWAK, A
    KADYKOW, M
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 34 (04) : 377 - 380
  • [7] PHARMACOKINETIC PROFILE OF SULFISOXAZOLE FOLLOWING INTRAVENOUS, INTRAMUSCULAR, AND ORAL ADMINISTRATION TO MAN
    KAPLAN, SA
    WEINFELD, RE
    ABRUZZO, CW
    LEWIS, M
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1972, 61 (05) : 773 - &
  • [8] Pharmacokinetic studies of meloxicam following oral and transdermal administration in Beagle dogs
    Yue Yuan
    Xiao-yan Chen
    San-ming Li
    Xiu-yan Wei
    Hui-min Yao
    Da-fang Zhong
    Acta Pharmacologica Sinica, 2009, 30 : 1060 - 1064
  • [9] A Pharmacokinetic Comparison of Meloxicam and Ketoprofen following Oral Administration to Healthy Dogs
    L. Montoya
    L. Ambros
    V. Kreil
    R. Bonafine
    G. Albarellos
    R. Hallu
    A. Soraci
    Veterinary Research Communications, 2004, 28 : 415 - 428
  • [10] Pharmacokinetic analysis of mosapride following intravenous and oral administration in beagle dogs
    Kim, Min-Soo
    Baek, In-hwan
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2020, 43 (05) : 454 - 460